Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis

BACKGROUND: Understanding the earliest manifestations of Alzheimer’s disease (AD) is key to realising disease-modifying treatments. Advances in neuroimaging and fluid biomarkers have improved our ability to identify AD pathology in vivo. The critical next step is improved detection and staging of ea...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Connor, Antoinette, Weston, Philip S. J., Pavisic, Ivanna M., Ryan, Natalie S., Collins, Jessica D., Lu, Kirsty, Crutch, Sebastian J., Alexander, Daniel C., Fox, Nick C., Oxtoby, Neil P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539456/
https://www.ncbi.nlm.nih.gov/pubmed/33023653
http://dx.doi.org/10.1186/s13195-020-00695-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539456/
https://www.ncbi.nlm.nih.gov/pubmed/33023653
http://dx.doi.org/10.1186/s13195-020-00695-2

Ejemplares similares